Living With Fibrosis Our Patients ↓ We Are Here For Hope Here at Pliant, the world’s top experts in fibrosis biology are hard at work with experienced drug developers to find safe and effective therapies for people with idiopathic pulmonary fibrosis (IPF), primary sclerosing cholangitis (PSC), and other fibrotic diseases. Video Player https://pliantrx.com/wp-content/uploads/2021/08/Bernard-PFAM-Welcome.mp4 00:00 01:52 Bernard Coulie talks about Pliant’s commitment to working with the Pulmonary Fibrosis Foundation (PFF) and advancing therapies for people living with debilitating fibrotic diseases. Clinical Trials for Idiopathic Pulmonary Fibrosis (IPF) We are currently enrolling patients with idiopathic pulmonary fibrosis (IPF) in Phase 2 clinical trials for our lead investigational medicine, PLN-74809. IPF Clinical Trial → Clinical Trials for Primary Sclerosing Cholangitis (PSC) We are currently enrolling patients with primary sclerosing cholangitis (PSC) in Phase 2a clinical trials for our lead investigational medicine, PLN-74809. PSC Clinical Trial → Patient Resources What to expect in the INTEGRIS-IPF clinical trial Learn More → What to expect in the INTEGRIS-PSC clinical trial Learn More → Clinical Trial FAQs Learn More → Organizations Community Find support and more information about fibrotic disease and how to participate in clinical trials from the following organizations. About Our Science Pipeline Patients Investors & Media Careers Contact Terms of Use Privacy Notice CCPA Applicant and Staff Privacy Notice Copyright © 2021 Pliant Therapeutics, Inc. | All Rights Reserved

Board of Directors Hoyoung Huh, M.D., Ph.D. Chairman Suzanne Bruhn, Ph.D. Board Member Bernard Coulie, M.D., Ph.D. President and Chief Executive Officer Gayle Crowell Board Member John Curnutte, M.D. Board Member Neil Exter Board Member Charles Homcy, M.D. Board Member David Pyott Board Member Smital Shah Board Member Our Team Our Team Pliant is led by a team of world-renowned fibrosis researchers and highly experienced drug developers focused on translating science into novel therapies for patients in need. Leadership → Scientific Founders → Board of Directors → Scientific Advisory Board → About Our Science Pipeline Patients Investors & Media Careers Contact Terms of Use Privacy Notice CCPA Applicant and Staff Privacy Notice Copyright © 2021 Pliant Therapeutics, Inc. | All Rights Reserved